triple glp 1 agonist Hitting the G Spot: The New Triple G for Weight Loss retatrutide triple agonist glp-1 gip

A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

Discover essential guidance on interactions, monitoring requirements, and safety considerations for combining GLP-1 receptor agonists with thyroid hormone replacement therapy.

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Glucagon-like peptide1 receptor agonists (GLP-1RAs) have emerged as a transformative class of therapies initially developed for glycemic control in type2 diabetes mellitus